Background The stress hyperglycemia ratio (SHR) reflects relative hyperglycemia during acute physiological stress. Its prognostic value in pulmonary embolism (PE), particularly in patients with PE recorded as a nonprincipal diagnosis during a hospitalization involving intensive care unit admi.ssion (operationally defined as secondary PE), remains unclear. Using the MIMIC-IV database, we investigated the association between SHR and 1-year all-cause mortality in patients with secondary PE. Methods This retrospective cohort study included patients with PE from MIMIC-IV version 2.2. Patients with PE recorded as the principal diagnosis for the hospitalization were excluded; therefore, the cohort comprised patients with operationally defined secondary PE. Patients were categorized into SHR quartiles. The primary outcome was 1-year all-cause mortality. Associations were assessed using Cox proportional hazards models and restricted cubic spline analyses. Covariates were selected a priori based on prior evidence, clinical relevance, and biological plausibility. Multicollinearity was assessed using variance inflation factors. Subgroup analyses were exploratory, with Bonferroni-corrected interaction P values reported. Results A total of 784 patients were included; 49.49% were male. In-hospital and 1-year mortality rates were 4.21% and 20.41%, respectively. In the fully adjusted Cox model, the highest SHR quartile was associated with higher 1-year mortality than the lowest quartile (hazard ratio [HR] = 1.49, 95% confidence interval [CI]: 1.01–2.24, P = 0.049), with a significant trend ( P = 0.045). Restricted cubic spline analyses showed a visually J-shaped trend in the association between SHR and 1-year all-cause mortality; however, the tests for non-linearity were not statistically significant (P for non-linearity = 0.623). The apparent curve pattern should therefore be interpreted cautiously. An exploratory interaction with insurance type was observed before but not after Bonferroni correction. Conclusions Higher SHR was associated with increased 1-year all-cause mortality in patients with secondary PE, suggesting potential prognostic value for longer-term risk assessment. Although the restricted cubic spline curve showed a visually J-shaped trend, the non-linearity test was not statistically significant; therefore, this apparent pattern requires confirmation in future studies. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: